Professeur J-J Body, Endocrinologie - Maladies Osseuses
0672.875.241 · rovalta.com · 28/09/2026
Professeur J-J Body, Endocrinologie - Maladies Osseuses
Financial year 2025 · Closed on 30/09/2025
Overview
Identity
Source · BCE/KBOProfesseur J-J Body, Endocrinologie - Maladies Osseuses is a Private limited company incorporated in 2017. Its main activity is: General medical practice activities. Its registered office is in Ganshoren.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0672.875.241
- Incorporation
- 21/03/2017
- Legal form
- Private limited company
- Registered office
- Avenue Henri Feuillien 35
1083 Ganshoren · BruxellesSee on map - Contributed capital
- 18 600,00 €
- Latest accounts
- 30/09/2025
Financials
Source · NBB, 8 filingsTrend over 8 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 58,8 k € | -4.1% | 61,3 k € | +5.5% | 58,1 k € | +85.4% | 31,4 k € | -48.1% | 60,4 k € |
| EBITDA | 57,6 k € | -4.2% | 60,2 k € | +4.9% | 57,3 k € | +122% | 25,9 k € | -57.0% | 60,1 k € |
| Operating result | 52,8 k € | -4.5% | 55,3 k € | +2.3% | 54 k € | +123% | 24,2 k € | -59.1% | 59,1 k € |
| Net result | 38,2 k € | -3.7% | 39,6 k € | +4.0% | 38,1 k € | +140% | 15,8 k € | -62.2% | 41,9 k € |
| Balance sheet | |||||||||
| Equity | 20,5 k € | 0.0% | 20,5 k € | 0.0% | 20,5 k € | 0.0% | 20,5 k € | 0.0% | 20,5 k € |
| Total assets | 71,2 k € | -5.9% | 75,6 k € | +12.5% | 67,2 k € | +35.9% | 49,5 k € | -78.3% | 228,3 k € |
| Cash | 61,3 k € | -3.8% | 63,7 k € | +37.0% | 46,5 k € | +92.3% | 24,2 k € | -89.1% | 220,8 k € |
| Debts | 50,7 k € | -8.1% | 55,2 k € | +17.9% | 46,8 k € | +61.2% | 29 k € | -86.0% | 207,9 k € |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 30/09/20251 active
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
Jean-Jacques Body | DirectorManagerended |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/10/2024 | 01/10/2023 | 01/10/2022 | 01/10/2021 | 01/10/2020 | 01/10/2019 |
| Closing of the financial year | 30/09/2025 | 30/09/2024 | 30/09/2023 | 30/09/2022 | 30/09/2021 | 30/09/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 20/04/2026 | 29/04/2025 | 30/04/2024 | 28/04/2023 | 29/04/2022 | 30/04/2021 |
| General meeting | 06/03/2026 | 07/03/2025 | 01/03/2024 | 03/03/2023 | 04/03/2022 | 05/03/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 8 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 30/09/2025 | 06/03/2026 | 20/04/2026 | French | |
| Micro model | 30/09/2024 | 07/03/2025 | 29/04/2025 | French | |
| Micro model | 30/09/2023 | 01/03/2024 | 30/04/2024 | French | |
| Micro model | 30/09/2022 | 03/03/2023 | 28/04/2023 | French | |
| Micro model | 30/09/2021 | 04/03/2022 | 29/04/2022 | French | |
| Micro model | 30/09/2020 | 05/03/2021 | 30/04/2021 | French | |
| Micro model | 30/09/2019 | 06/03/2020 | 29/04/2020 | French | |
| Micro model | 30/09/2018 | 01/03/2019 | 30/04/2019 | French |
Valuation
Indicative valuation
As an indication, this company is worth
between 250 k€ and 500 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 30/09/20251 active
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
Jean-Jacques Body | DirectorManagerended |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official GazetteSimilar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsRegistered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Avenue Henri Feuillien 35, 1083 GanshorenCurrent | accounts 2021 → 2025 | Accounts 2025 · 2026-00084277 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| Professeur J-J Body, Endocrinologie - Maladies OsseusesCurrent | CBE | |
| SRL Professeur J-J Body, Endocrinologie | accounts 2022 → 2025 | Accounts 2025 · 2026-00084277 |
| Professeur J-J Body, Endocrinologie - Maladies Osseuses | accounts 2021 | Accounts 2021 · 2022-20021268 |
Events
- 2025Annual accounts 202538,2 k €↓
- 2024Annual accounts 202439,6 k €↑
- 2023Annual accounts 202338,1 k €↑
- 2022Annual accounts 202215,8 k €↓
- 2022Name changeSRL Professeur J-J Body, Endocrinologie
- 2021Annual accounts 202141,9 k €↓
- 2020Annual accounts 202043,9 k €↓
- 2019Annual accounts 201947,4 k €↓
- 2018Annual accounts 201863,9 k €
- 21/03/2017IncorporationPrivate limited company